1.

Which of the following is an NSAID for Alzheimer’s disease, that lead to Phase III clinical trials?(a) Bapineuzumab(b) Alzhemed(c) Flurizan(d) Doxil

Answer» The correct answer is (c) Flurizan

Explanation: Flurizan was the non-steroidal anti-inflammatory drug or NSAID for treating Alzheimer’s which reached the stage of phase III clinical trials but could proceed thereafter.


Discussion

No Comment Found

Related InterviewSolutions